These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 11326233

  • 1. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device.
    Madigan JD, Barbone A, Choudhri AF, Morales DL, Cai B, Oz MC, Burkhoff D.
    J Thorac Cardiovasc Surg; 2001 May; 121(5):902-8. PubMed ID: 11326233
    [Abstract] [Full Text] [Related]

  • 2. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S, Naka Y, Oz MC, Burkhoff D.
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [Abstract] [Full Text] [Related]

  • 3. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart.
    Chaudhary KW, Rossman EI, Piacentino V, Kenessey A, Weber C, Gaughan JP, Ojamaa K, Klein I, Bers DM, Houser SR, Margulies KB.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):837-45. PubMed ID: 15312868
    [Abstract] [Full Text] [Related]

  • 4. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S, Foronjy RF, Dickstein ML, Gu A, Garrelds IM, Danser AH, Oz MC, D'Armiento J, Burkhoff D.
    Circulation; 2005 Jul 19; 112(3):364-74. PubMed ID: 15998679
    [Abstract] [Full Text] [Related]

  • 5. Cardiomyopathic etiology and SERCA2a reverse remodeling during mechanical support of the failing human heart.
    Heerdt PM, Klotz S, Burkhoff D.
    Anesth Analg; 2006 Jan 19; 102(1):32-7. PubMed ID: 16368801
    [Abstract] [Full Text] [Related]

  • 6. The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling.
    Milting H, Jacob M, Kassner A, Heimann P, Mannherz HG, Becker G, Meyer HE, Böthig D, Arusoglu L, Morshuis M, Körfer R, El Banayosy A.
    J Heart Lung Transplant; 2004 Apr 19; 23(4):396-404. PubMed ID: 15063398
    [Abstract] [Full Text] [Related]

  • 7. Duration of left ventricular assist device support: Effects on abnormal calcium cycling and functional recovery in the failing human heart.
    Ogletree ML, Sweet WE, Talerico C, Klecka ME, Young JB, Smedira NG, Starling RC, Moravec CS.
    J Heart Lung Transplant; 2010 May 19; 29(5):554-61. PubMed ID: 20044278
    [Abstract] [Full Text] [Related]

  • 8. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S, Barbone A, Reiken S, Holmes JW, Naka Y, Oz MC, Marks AR, Burkhoff D.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):668-76. PubMed ID: 15734609
    [Abstract] [Full Text] [Related]

  • 9. Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading.
    Wohlschlaeger J, Schmitz KJ, Palatty J, Takeda A, Takeda N, Vahlhaus C, Levkau B, Stypmann J, Schmid C, Schmid KW, Baba HA.
    J Thorac Cardiovasc Surg; 2007 Jan 01; 133(1):37-43. PubMed ID: 17198778
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
    Soderlund KA, Chivukula RR, Russell SD, Conte JV, Mudd JO, Halushka MK.
    Cardiovasc Pathol; 2009 Jan 01; 18(4):217-22. PubMed ID: 18706833
    [Abstract] [Full Text] [Related]

  • 11. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y, Sawa Y, Takewa Y, Tatsumi E, Kaneda Y, Taenaka Y, Matsuda H.
    J Thorac Cardiovasc Surg; 2005 Sep 01; 130(3):624-32. PubMed ID: 16153905
    [Abstract] [Full Text] [Related]

  • 12. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS.
    Curr Opin Cardiol; 1998 May 01; 13(3):156-61. PubMed ID: 9649937
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.
    Kuhn M, Voss M, Mitko D, Stypmann J, Schmid C, Kawaguchi N, Grabellus F, Baba HA.
    Cardiovasc Res; 2004 Nov 01; 64(2):308-14. PubMed ID: 15485690
    [Abstract] [Full Text] [Related]

  • 16. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S, Danser AH, Foronjy RF, Oz MC, Wang J, Mancini D, D'Armiento J, Burkhoff D.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1166-74. PubMed ID: 17367660
    [Abstract] [Full Text] [Related]

  • 17. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.
    Bruggink AH, van Oosterhout MF, de Jonge N, Ivangh B, van Kuik J, Voorbij RH, Cleutjens JP, Gmelig-Meyling FH, de Weger RA.
    J Heart Lung Transplant; 2006 Sep 20; 25(9):1091-8. PubMed ID: 16962471
    [Abstract] [Full Text] [Related]

  • 18. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy.
    Terracciano CM, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH.
    Circulation; 2004 May 18; 109(19):2263-5. PubMed ID: 15136495
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of partial ventricular support in chronic heart failure: results of simulation validated with in vivo data.
    Morley D, Litwak K, Ferber P, Spence P, Dowling R, Meyns B, Griffith B, Burkhoff D.
    J Thorac Cardiovasc Surg; 2007 Jan 18; 133(1):21-8. PubMed ID: 17198776
    [Abstract] [Full Text] [Related]

  • 20. Duration of left ventricular assist device support affects transplant survival.
    Ashton RC, Goldstein DJ, Rose EA, Weinberg AD, Levin HR, Oz MC.
    J Heart Lung Transplant; 1996 Nov 18; 15(11):1151-7. PubMed ID: 8956124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.